The complex link among heart failure, atrial fibrillation, and lung diseases, and an update on cardiac transplantation
Key result
This editorial highlights that restrictive lung physiology increases incident heart failure risk (HR 1.43) and baseline atrial fibrillation attenuates the benefit of omecamtiv mecarbil in HFrEF.
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
This editorial provides a comprehensive overview of recent heart failure research, emphasizing the interplay between HF, lung disease, and atrial fibrillation, alongside global treatment disparities.
PICO
P
Population
Heart failure, atrial fibrillation, lung diseases, cardiac transplantation
This editorial provides a comprehensive overview of recent heart failure research, emphasizing the interplay between HF, lung disease, and atrial fibrillation, alongside global treatment disparities.
Cite This Study
Filippo Crea (2022) conducted an editorial in Heart failure, atrial fibrillation, lung diseases, cardiac transplantation. This editorial highlights that restrictive lung physiology increases incident heart failure risk (HR 1.43) and baseline atrial fibrillation attenuates the benefit of omecamtiv mecarbil in HFrEF.